The COVID-19 vaccine developed by Pfizer and BioNTech has been approved in the entire European Union after the USA, UK, and Canada citizens already took it. But we have to face the facts that not everyone wants to get vaccinated for the coronavirus. Furthermore, a new report reveals that the Pfizer vaccine is the culprit for more allergic reactions than expected.
Pfizer researchers are seen as true heroes for developing the COVID-19 vaccine, and there’s no real reason to believe that they won’t remain so for a long time. However, the National Institutes of Health from the US is analyzing along with the vaccine makers the possibility of holding clinical trials for very allergic people.
Allergic reactions are rising
The chief scientific adviser for Operation Warp Speed, Dr. Moncef Slaoui, brings us the not so pleasant news that the frequency of allergic reactions to the Pfizer-BioNTech vaccine for COVID-19 is higher by comparison with other jabs.
But even with the vaccine rollout, people will keep getting infected with the coronavirus if they don’t get the drug. Shane Reichardt, the spokesman for the emergency management department from Riverside County, declared:
No matter where you stand politically, it’s fairly undeniable that when people start getting together and congregating over holidays, et cetera, we see a corresponding bump in the number of cases.
The Moderna vaccine will also be involved in the new study, as Slaoui declared:
There is now advanced planning for a study in highly allergic individuals in clinical trials to test the Moderna and Pfizer vaccines and try to understand the immune mechanisms that are underpinning any reactions.
The Centers for Disease Control and Prevention informs us that the evidence gathered from clinical trials reveals that the Pfizer-BioNTech vaccine is 95% effective at preventing COVID-19 illness.